NCT00501462 A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function Status COMPLETED Phase PHASE1
NCT00501397 A Study of the Effects of Ketoconazole Taken Orally Has on the PK Profiles of a Dose of GSK189075 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00501267 A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder Status COMPLETED Phase PHASE1
NCT00501020 Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of Metformin Status COMPLETED Phase PHASE4
NCT00500461 Study To Examine Safety, Tolerability And Pharmacokinetics Of Intravenous Doses And Oral Dose Of GSK233705 Status COMPLETED Phase PHASE1
NCT00500331 Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM) Status COMPLETED Phase PHASE2
NCT00500201 A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets. Status COMPLETED Phase PHASE1
NCT00500058 A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18 Status COMPLETED Phase PHASE1
NCT00499928 A Study To Investigate The Metabolism And Excretion Of 14C SB-751689 Given To Healthy Males And Postmenopausal Women Status COMPLETED Phase PHASE1
NCT00499824 GIANT: General Practitioner Implementation in Asia of Normoglycaemic Targets Status COMPLETED Phase NA
NCT00499707 Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects Status COMPLETED Phase PHASE3
NCT00496015 Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A Status COMPLETED Phase PHASE3
NCT00495729 15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects. Status COMPLETED Phase PHASE1
NCT00495469 Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive Status COMPLETED Phase PHASE2
NCT00495014 Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects Status COMPLETED Phase PHASE1
NCT00494780 Ofatumumab (Humax-CD20) With CHOP (Cyclophosphamide,Doxorubicin, Vincristine, Predisolone) in Follicular Lymphoma (FL) Patients Status COMPLETED Phase PHASE2
NCT00494767 Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs Status COMPLETED Phase PHASE1
NCT00493896 Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients Status TERMINATED Phase PHASE3